Targeted theranostic nanomedicine using targeted CT-imageable particles that release tebentafusp.
Theranostic nanomedicine demonstrated potential as a dual therapeutic and diagnostic strategy for targeting tumors and metastases, with synergistic effects observed when combined with radiation.
Authors
- Takahiro Sato (ORCID: https://orcid.org/0000-0002-2925-7710)
- Katsunari Yoshioka (ORCID: https://orcid.org/0000-0003-0964-8631)
- Satoshi Harada (ORCID: https://orcid.org/0009-0001-2208-9689)
Institutions
- Iwate Medical University (JP)
- National Institutes for Quantum Science and Technology (JP)
Publication Details
- Journal
- Japanese Journal of Radiology
- Published
- 2025-04-17
- DOI
- https://doi.org/10.1007/s11604-025-01782-w
- Primary Topic
- Nanoplatforms for cancer theranostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- University of Tokyo
- Japan Atomic Energy Research Institute
- National Institutes for Quantum and Radiological Science and Technology
- Japan Society for the Promotion of Science
- Japan Atomic Energy Agency